News Releases :: Skye Bioscience, Inc. (SKYE)

Year

Category

Mar 14, 2025 7:00 am EDT

Skye Bioscience to Announce 2024 Financial Results on March 20th, 2025

Feb 27, 2025 6:00 pm EST

Skye Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Feb 24, 2025 7:00 am EST

Skye Bioscience to Participate in SXSW Session on Obesity

Feb 20, 2025 7:00 am EST

Skye Bioscience to Present at TD Cowen Health Care Conference

Feb 4, 2025 7:00 am EST

Skye Bioscience Announces Participation in February Conferences

Jan 13, 2025 7:00 am EST

Skye Bioscience Provides 2025 Look Ahead and Year in Review

Dec 19, 2024 7:00 am EST

Skye Bioscience to Present at J.P. Morgan Healthcare Conference

Nov 18, 2024 7:00 am EST

Skye Bioscience to Participate in Upcoming December Healthcare Investment Conferences

Nov 14, 2024 7:00 am EST

Skye Bioscience Surpasses 50% Patient Enrollment in Phase 2 Obesity Study of Differentiated CB1 Inhibitor

Nov 7, 2024 4:01 pm EST

Skye Bioscience Reports Third Quarter 2024 Financial Results and Recent Highlights